Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus

E Trinka, M Leitinger - CONTINUUM: Lifelong Learning in …, 2022 - journals.lww.com
PURPOSE OF REVIEW Status epilepticus is a serious condition caused by disorders and
diseases that affect the central nervous system. In status epilepticus, hypersynchronous …

Unraveling the enigma of new‐onset refractory status epilepticus: a systematic review of aetiologies

S Lattanzi, M Leitinger, C Rocchi… - European Journal of …, 2022 - Wiley Online Library
Background and purpose New‐onset refractory status epilepticus (NORSE) is a clinical
presentation, neither a specific diagnosis nor a clinical entity. It refers to a patient without …

Эпилепсия у детей и взрослых женщин и мужчин

ВА Карлов - 2019 - elibrary.ru
В руководстве представлены результаты 60-летней работы автора в области детской
и взрослой неврологии и эпилептологии. Впервые эпилептология представлена в …

Epidemiology-based mortality score in status epilepticus (EMSE)

M Leitinger, Y Höller, G Kalss, A Rohracher, HF Novak… - Neurocritical care, 2015 - Springer
Background Status epilepticus (SE) is a neurological emergency with high mortality and
often a poor functional outcome amongst survivors. So far, only status epilepticus severity …

[HTML][HTML] 25 years of advances in the definition, classification and treatment of status epilepticus

E Trinka, R Kälviäinen - Seizure, 2017 - Elsevier
Purpose Status epilepticus (SE) requires not only urgent symptomatic treatment with
antiepileptic drugs but also rapid identification and treatment of its cause. This narrative …

[HTML][HTML] Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022

HE Bays, A Fitch, S Christensen, K Burridge, J Tondt - Obesity Pillars, 2022 - Elsevier
Abstract Background This “Anti-Obesity Medications and Investigational Agents: An Obesity
Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an …

Intravenous ganaxolone for the treatment of refractory status epilepticus: results from an open‐label, dose‐finding, phase 2 trial

H Vaitkevicius, RE Ramsay, CB Swisher… - …, 2022 - Wiley Online Library
Objective Patients with refractory status epilepticus (RSE) have failed treatment with
benzodiazepines and≥ 1 second‐line intravenous (IV) antiseizure medication (ASM) …

Dogs as a natural animal model of epilepsy

W Löscher - Frontiers in veterinary science, 2022 - frontiersin.org
Epilepsy is a common neurological disease in both humans and domestic dogs, making
dogs an ideal translational model of epilepsy. In both species, epilepsy is a complex brain …

PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

V Villanueva, W D'Souza, H Goji, DW Kim, C Liguori… - Journal of …, 2022 - Springer
The PER a M panel pooled analys I s of effec T iveness and tolerability (PERMIT) study was
a pooled analysis of data from 44 real-world studies from 17 countries, in which people with …

The evolution of the pilocarpine animal model of status epilepticus

IIA Juvale, ATC Has - Heliyon, 2020 - cell.com
The pilocarpine animal model of status epilepticus is a well-established, clinically
translatable model that satisfies all of the criteria essential for an animal model of status …